DAVID CRAIG: Open Payments
NPI 1407518442 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 45 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $202 |
| Vanda Pharmaceuticals Inc. | 5 | $92 |
| PFIZER INC. | 3 | $75 |
| UCB, Inc. | 3 | $68 |
| Biogen, Inc. | 3 | $65 |
| CSL Behring | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| SK Life Science, Inc. | 2 | $43 |
| Genentech USA, Inc. | 2 | $42 |
Products named: QULIPTA, PONVORY, NURTEC ODT, Hizentra, SKYCLARYS, AUSTEDO XR, Ocrevus Zunovo, Fintepla.
Industry payments across FL — which companies pay providers there.
